CorVista System with PH Add-On vs Viz RV/LV
AI Verdict
Choose CorVista System with PH Add-On if…
Choose CorVista System with PH Add-On if you need a rapid, non-invasive, point-of-care diagnostic solution for the initial assessment of coronary artery disease and pulmonary hypertension. This system is ideal for settings where quick results are crucial and avoiding radiation, contrast agents, or extensive patient preparation is a priority.
View CorVista System with PH Add-On →Choose Viz RV/LV if…
Choose Viz RV/LV if you need to rapidly and automatically stratify pulmonary embolism risk by analyzing existing CTPA scans for right and left ventricular diameter measurements. This tool is best suited for emergency or critical care settings where timely identification of RV strain is crucial for guiding treatment decisions and facilitating seamless communication among care teams regarding suspected PE cases.
View Viz RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CorVista System with PH Add-On | Viz RV/LV |
|---|---|---|
| Deployment | Cloud-based, point-of-care system. | Cloud-based |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CorVista System with PH Add-OnTool A, the CorVista System, offers superior usability by providing a non-invasive, point-of-care diagnostic solution that eliminates the need for radiation, contrast agents, injections, fasting, or exercise. This significantly reduces patient burden and streamlines the diagnostic workflow, with rapid results available within minutes.
Clinical Value
CorVista System with PH Add-OnBoth tools are FDA-cleared and provide significant clinical value. However, Tool A offers a broader diagnostic platform for two major cardiovascular diseases, coronary artery disease and pulmonary hypertension, with high sensitivity and specificity for earlier detection and diagnosis. Tool B, while crucial for pulmonary embolism risk stratification, focuses on a more specific measurement within an existing imaging workflow.
Pricing & Value
Viz RV/LVWhile both tools require direct contact for pricing, Viz.ai (Tool B) has a documented reimbursement pathway through the CMS New Technology Add-on Payment (NTAP) program for its solutions, which can help hospitals offset costs. This transparency in potential reimbursement mechanisms provides a clearer path to value realization for healthcare providers compared to Tool A's general claim of economic benefit.
Enterprise Readiness
Viz RV/LVViz.ai (Tool B) demonstrates stronger enterprise readiness with explicit HIPAA compliance, confirmed Business Associate Agreement (BAA), and a comprehensive 'Trust Center' providing detailed security and privacy documentation and certifications like SOC 2 Type II and ISO. Its integration into the broader Viz PE Solution with AI-powered alerts and a communication platform further highlights its robust capabilities for seamless enterprise-wide deployment and care coordination.
Innovation
CorVista System with PH Add-OnBoth tools leverage AI innovatively, but Tool A's non-invasive, point-of-care diagnostic approach for complex cardiovascular diseases, eliminating traditional burdens like radiation and injections, represents a more disruptive and pioneering innovation in diagnostic methodology. Its FDA Breakthrough Device designation for the PH Add-On further underscores its innovative potential.
Support & Docs
Viz RV/LVViz.ai (Tool B) clearly outlines its customer support channels, including a dedicated help center, knowledge base, troubleshooting guides, and 24/7 urgent phone support, along with customer resources and a 'Viz Academy' for training. In contrast, specific support and documentation resources for the CorVista System (Tool A) are not readily available through public searches.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CorVista System with PH Add-On | Viz RV/LV |
|---|---|---|
| Name | CorVista System with PH Add-On | Viz RV/LV |
| Company | Analytics for Life | Viz.ai |
| Description | The CorVista System with PH Add-On is an FDA-cleared, non-invasive, point-of-care AI diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension using machine-learned algorithms. | Viz RV/LV by Viz.ai is an FDA-cleared AI algorithm that automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution. |
| Key Features | Non-invasive cardiovascular diagnostics, Point-of-care testing, Machine-learned algorithms for analysis, Analyzes cardiac and hemodynamic signals, No radiation, contrast agents, injections, fasting, or exercise required, Rapid results available within minutes, Secure web portal for physician access to analysis, Modular design with disease-specific add-ons (CAD, PH) | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement, Analysis of volumetric CTPA acquisitions, AI algorithm for identification and measurement of heart ventricles, Provides annotated images showing ventricular measurements, Seamless component of the Viz PE Solution for suspected pulmonary embolism detection, AI-powered alerts and notifications to care teams, High-fidelity mobile DICOM image viewer, HIPAA-compliant communication platform for care coordination |
| Specialties | Cardiology, Internal Medicine, Pulmonology | Emergency Medicine, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring CorVista System with PH Add-On and Viz RV/LV.